The two most common forms of X-linked adrenoleukodystrophy (X-ALD), th
e childhood cerebral form (CCER) and the adult form, adrenomyeloneurop
athy (AMN), arise from the same mutations in the X-ALD gene at Xq28. T
hese two forms are distinguished by the degree of cerebral inflammatio
n. Segregation analysis suggests that an autosomal modifying gene may
be a major determinant of phenotype in X-ALD. Thus, a modifying gene c
ould be involved in initiating or promoting the inflammatory response.
In this study we detected a difference in tumor necrosis factor-alpha
(TNF-alpha) bioactivity, but not TNF-alpha protein levels, in serum f
rom some advanced CCER patients. Early-stage CCER patients and AMN pat
ients were in the normal range. Allelic differences in TNF-alpha or le
vels of soluble TNF receptor did not account for bioactivity differenc
es or phenotypic heterogeneity in X-ALD.